Adetola Henry Adewole
Adetola Henry Adewole has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Kolade Olatubosun Faloye
University of Ilesa
2 shared publications - Adedapo Oluwasanu Adeola
Department of Chemistry and Biochemistry and the Centre for NanoScience Research, Concordia University, Montreal, QC, H4B 1R6, Canada; Quebec Centre for Advanced Materials, Department of Chemistry and Biochemistry, Concordia University, Montreal, QC, H4B 1R6, Canada
1 shared publication - Adedibu Sunny Akingboye
Geophysics Programme, School of Physics, Universiti Sains Malaysia, Penang, Malaysia
1 shared publication Anne Marie Sweeney-Jones
School of Chemistry and Biochemistry
1 shared publicationBhuwan Khatri Chhetri
School of Chemistry and Biochemistry
1 shared publication- Blessing Ibukun Okunribido
Department of Chemistry, Faculty of Science, Obafemi Awolowo University, Ile-Ife 220101, Nigeria
1 shared publication
Latest Publications
- Open Access
- 22 October 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (11) , 2635-2644
Discovery of Na v 1.7 Inhibitors through the Screening of Marine Natural Product Extracts
Automated high-throughput screening of a prefractionated extract library of marine macroorganisms identified 239 hits (hit rate 2.5%), including a marine algal extract that blocked the Nav1.7 channel in a fluorescent-based flux assay. Bioactivity-guided chemical investigation led to the isolation of two glycoglycerolipids (1 and 2). In preliminary screening, 1 showed stronger Nav1.7 inhibition, while secondary screening using patch-clamp electrophysiology, which measures ion movement across membranes, revealed 2 as more potent. This study identified some ion channel modulators from diverse taxonomic origins, including red algae, sponges, and corals, many of which are underexplored and represent promising leads for future drug discovery.
- 22 October 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (11) , 2635-2644
Open AccessDiscovery of Na v 1.7 Inhibitors through the Screening of Marine Natural Product Extracts
Automated high-throughput screening of a prefractionated extract library of marine macroorganisms identified 239 hits (hit rate 2.5%), including a marine algal extract that blocked the Nav1.7 channel in a fluorescent-based flux assay. Bioactivity-guided chemical investigation led to the isolation of two glycoglycerolipids (1 and 2). In preliminary screening, 1 showed stronger Nav1.7 inhibition, while secondary screening using patch-clamp electrophysiology, which measures ion movement across membranes, revealed 2 as more potent. This study identified some ion channel modulators from diverse taxonomic origins, including red algae, sponges, and corals, many of which are underexplored and represent promising leads for future drug discovery.
- Open Access
Flavonoid in All Their Therapeutic Values: An Odyssey into the Phytochemistry and Pharmacology of Naturally Occurring Flavonoid from Genus Bauhinia
The genus Bauhinia has over 350 species distributed on different continents of the world. The vast majority of the species in this genus possess interesting biological activities. Also, they are good sources of flavonoids, which are known to elicit excellent pharmacological properties and are well-positioned as potential drug candidates. A literature search was performed with proper consideration of articles published and indexed in PubMed, Scopus, Springer Link, Google Scholar, ScienceDirect, SciFinder, and Medline databases between 1980 and 2023. A total of 164 flavonoids isolated from the genus Bauhinia were reviewed, and biological activities including antidiabetic, anti-cancer, antibacterial, cytotoxicity, antidiarrheal, antioxidant, anti-inflammatory, and anti-cataract were all reported. This study gave a comprehensive review of these flavonoids through detailed classification, structural diversity, and pharmacological activities.
Open AccessFlavonoid in All Their Therapeutic Values: An Odyssey into the Phytochemistry and Pharmacology of Naturally Occurring Flavonoid from Genus Bauhinia
The genus Bauhinia has over 350 species distributed on different continents of the world. The vast majority of the species in this genus possess interesting biological activities. Also, they are good sources of flavonoids, which are known to elicit excellent pharmacological properties and are well-positioned as potential drug candidates. A literature search was performed with proper consideration of articles published and indexed in PubMed, Scopus, Springer Link, Google Scholar, ScienceDirect, SciFinder, and Medline databases between 1980 and 2023. A total of 164 flavonoids isolated from the genus Bauhinia were reviewed, and biological activities including antidiabetic, anti-cancer, antibacterial, cytotoxicity, antidiarrheal, antioxidant, anti-inflammatory, and anti-cataract were all reported. This study gave a comprehensive review of these flavonoids through detailed classification, structural diversity, and pharmacological activities.
- 28 April 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (5) , 2570-2585
Antimalarial potential, LC–MS secondary metabolite profiling and computational studies of Zingiber officinale
Malaria is among the top-ranked parasitic diseases that pose a threat to the existence of the human race. This study evaluated the antimalarial effect of the rhizome of Zingiber officinale in infected mice, performed secondary metabolite profiling and detailed computational antimalarial evaluation through molecular docking, molecular dynamics (MD) simulation and density functional theory methods. The antimalarial potential of Z. officinale was performed using the in vivo chemosuppressive model; secondary metabolite profiling was carried out using liquid chromatography–mass spectrometry (LC–MS). Molecular docking was performed with Autodock Vina while the MD simulation was performed with Schrodinger desmond suite for 100 ns and DFT calculations with B3LYP (6-31G) basis set. The extract showed 64% parasitaemia suppression, with a dose-dependent increase in activity up to 200 mg/kg. The chemical profiling of the extract tentatively identified eight phytochemicals. The molecular docking studies with plasmepsin II and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS) identified gingerenone A as the hit molecule, and MMGBSA values corroborate the binding energies obtained. The electronic parameters of gingerenone A revealed its significant antimalarial potential. The antimalarial activity elicited by the extract of Z. officinale and the bioactive chemical constituent supports its usage in ethnomedicine. Communicated by Ramaswamy H. Sarma
- 28 April 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (5) , 2570-2585
Antimalarial potential, LC–MS secondary metabolite profiling and computational studies of Zingiber officinale
Malaria is among the top-ranked parasitic diseases that pose a threat to the existence of the human race. This study evaluated the antimalarial effect of the rhizome of Zingiber officinale in infected mice, performed secondary metabolite profiling and detailed computational antimalarial evaluation through molecular docking, molecular dynamics (MD) simulation and density functional theory methods. The antimalarial potential of Z. officinale was performed using the in vivo chemosuppressive model; secondary metabolite profiling was carried out using liquid chromatography–mass spectrometry (LC–MS). Molecular docking was performed with Autodock Vina while the MD simulation was performed with Schrodinger desmond suite for 100 ns and DFT calculations with B3LYP (6-31G) basis set. The extract showed 64% parasitaemia suppression, with a dose-dependent increase in activity up to 200 mg/kg. The chemical profiling of the extract tentatively identified eight phytochemicals. The molecular docking studies with plasmepsin II and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS) identified gingerenone A as the hit molecule, and MMGBSA values corroborate the binding energies obtained. The electronic parameters of gingerenone A revealed its significant antimalarial potential. The antimalarial activity elicited by the extract of Z. officinale and the bioactive chemical constituent supports its usage in ethnomedicine. Communicated by Ramaswamy H. Sarma
- Open Access
- 17 November 2022
- Published by Wiley in Chemistry & Biodiversity
- Vol. 19 (12) , e202200837
Antifungal Compounds from the Leaves of Rhynchosia minima
Rhynchosia minima, commonly known as jumby bean, is used as a remedy for respiratory ailments in various parts of the world. It is also used by South African traditional healers to treat heart or chest pain. This study aimed to investigate the bioactive constituents of the leaf extracts of R. minima against selected fungal isolates that have been identified as risk factors in respiratory illness. Rhynchosia minima leaves were extracted sequentially using hexane, dichloromethane, ethyl acetate and methanol in increasing order of polarity. The extracts were subjected to repeated chromatographic techniques, for phytochemical isolation. The extracts and isolated compounds were screened against Candida albicans and Cryptococcus neoformans by determining the minimum concentration that inhibited fungal growth. Six flavonoids, one norisoprenoid and one cyclitol were isolated and characterized by 1D and 2D NMR and HR‐ESI‐MS. The extracts obtained in the study had moderate to weak antifungal activities, with MICs ranging from 312.5 to 1250.0 μg/mL against both fungi. Four isolated compounds were also screened, with two of them exhibiting activity against C. albicans (MIC=6.25 μg/mL) that was comparable to amphotericin B, the positive control. These two compounds also had better antifungal potential against C. neoformans with an MIC=6.25 μg/mL, compared to the MIC of 12.5 μg/mL of amphotericin B. Seven of the eight isolated compounds were obtained from the extracts of Rhynchosia minima for the first time. Two of the isolated compounds demonstrated activity comparable or superior to amphotericin B activity. The notable potency displayed by these compounds warrants further investigation on their development as antifungal agents.
- 17 November 2022
- Published by Wiley in Chemistry & Biodiversity
- Vol. 19 (12) , e202200837
Open AccessAntifungal Compounds from the Leaves of Rhynchosia minima
Rhynchosia minima, commonly known as jumby bean, is used as a remedy for respiratory ailments in various parts of the world. It is also used by South African traditional healers to treat heart or chest pain. This study aimed to investigate the bioactive constituents of the leaf extracts of R. minima against selected fungal isolates that have been identified as risk factors in respiratory illness. Rhynchosia minima leaves were extracted sequentially using hexane, dichloromethane, ethyl acetate and methanol in increasing order of polarity. The extracts were subjected to repeated chromatographic techniques, for phytochemical isolation. The extracts and isolated compounds were screened against Candida albicans and Cryptococcus neoformans by determining the minimum concentration that inhibited fungal growth. Six flavonoids, one norisoprenoid and one cyclitol were isolated and characterized by 1D and 2D NMR and HR‐ESI‐MS. The extracts obtained in the study had moderate to weak antifungal activities, with MICs ranging from 312.5 to 1250.0 μg/mL against both fungi. Four isolated compounds were also screened, with two of them exhibiting activity against C. albicans (MIC=6.25 μg/mL) that was comparable to amphotericin B, the positive control. These two compounds also had better antifungal potential against C. neoformans with an MIC=6.25 μg/mL, compared to the MIC of 12.5 μg/mL of amphotericin B. Seven of the eight isolated compounds were obtained from the extracts of Rhynchosia minima for the first time. Two of the isolated compounds demonstrated activity comparable or superior to amphotericin B activity. The notable potency displayed by these compounds warrants further investigation on their development as antifungal agents.
- 26 February 2022
- Published by Springer Nature in Chemistry Africa
- Vol. 5 (3) , 481-508
Psychotropic Drugs of Emerging Concerns in Aquatic Systems: Ecotoxicology and Remediation Approaches
- 26 February 2022
- Published by Springer Nature in Chemistry Africa
- Vol. 5 (3) , 481-508
Psychotropic Drugs of Emerging Concerns in Aquatic Systems: Ecotoxicology and Remediation Approaches